Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mack Roach

Showing results (241-250 of 284) with videos related to

Pageof 29
Sort By:
La Radiologia Medica|October 13, 2025
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914)Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.
Advances in Radiation Oncology|September 12, 2018
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicitiesCanhua Xiao, Jennifer Moughan, Benjamin Movsas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical TrialJeff M Michalski, Kathryn A Winter, Bradley R Prestidge, et al.
European Urology|January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised TrialLoren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 24, 2025
Bridging the Gap: Enhancing Prostate Cancer Survivorship and Advocacy Among Ethnically Diverse Black Men Through Community Town HallsMotolani E Ogunsanya, Ernest Kaninjing, Sara M DeForge, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate CancerHimanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.
The Journal of Urology|September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public WorkshopChana Weinstock, Daniel Suzman, Paul Kluetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2007
Prostate cancer. Clinical practice guidelines in oncologyJames Mohler, Richard J Babaian, Robert R Bahnson, et al.
Brachytherapy|February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United StatesSteven J Frank, Peter D Grimm, John E Sylvester, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
Pageof 29

Showing results (241-250 of 284) with videos related to

Sort By:
Pageof 29
La Radiologia Medica|October 13, 2025
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914)Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, et al.
Advances in Radiation Oncology|September 12, 2018
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicitiesCanhua Xiao, Jennifer Moughan, Benjamin Movsas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical TrialJeff M Michalski, Kathryn A Winter, Bradley R Prestidge, et al.
European Urology|January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised TrialLoren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 24, 2025
Bridging the Gap: Enhancing Prostate Cancer Survivorship and Advocacy Among Ethnically Diverse Black Men Through Community Town HallsMotolani E Ogunsanya, Ernest Kaninjing, Sara M DeForge, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate CancerHimanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.
The Journal of Urology|September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public WorkshopChana Weinstock, Daniel Suzman, Paul Kluetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2007
Prostate cancer. Clinical practice guidelines in oncologyJames Mohler, Richard J Babaian, Robert R Bahnson, et al.
Brachytherapy|February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United StatesSteven J Frank, Peter D Grimm, John E Sylvester, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
Pageof 29